PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-282.98%
Negative net income growth while MRVL stands at 5.00%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
1.19%
Some D&A expansion while MRVL is negative at -0.85%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
205.00%
Deferred tax of 205.00% while MRVL is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
No Data
No Data available this quarter, please select a different quarter.
703.03%
Well above MRVL's 439.52% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
1200.00%
Inventory growth well above MRVL's 653.82%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
No Data
No Data available this quarter, please select a different quarter.
653.33%
Growth well above MRVL's 431.90%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
298.89%
Growth of 298.89% while MRVL is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might reflect intangible expansions or partial write-offs.
31.68%
Operating cash flow growth below 50% of MRVL's 5620.88%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
12.27%
Some CapEx rise while MRVL is negative at -92.43%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
-4.97%
Both yoy lines negative, with MRVL at -175.07%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-72.07%
We reduce yoy sales while MRVL is 45.55%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-2470.00%
Both yoy lines negative, with MRVL at -167.50%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
126.09%
Lower share issuance yoy vs. MRVL's 906.32%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
-414.29%
We cut yoy buybacks while MRVL is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.